Product image of Nocutil Melt (Desmopressin) supplied by GNH India

Nocutil Melt

Active Ingredient:
Desmopressin
Origin:
EU

Nocutil Melt (Desmopressin)

Desmopressin, the active ingredient in Nocutil Melt, is a vasopressin analog presented as a sublingual melt for sublingual use. It is employed to control central diabetes insipidus and nocturnal enuresis in children and adults, and to reduce bleeding in patients with hemophilia A or von Willebrand disease.

GNH India supplies Nocutil Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution to meet regulatory requirements.

Manufacturer / TM Owner

Gebro Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin is a synthetic vasopressin analog used to manage disorders of water balance and certain bleeding disorders.

  • Central diabetes insipidus: reduces polyuria by enhancing water reabsorption in the renal collecting ducts.
  • Nocturnal enuresis: decreases nighttime bladder emptying episodes by concentrating urine.
  • Hemophilia A: raises plasma factor VIII levels to improve clot formation.
  • Von Willebrand disease: elevates von Willebrand factor, helping control mucosal bleeding.

How It Works

  • Desmopressin selectively binds to V2 receptors on the basolateral membrane of renal collecting‑duct cells. Receptor activation stimulates adenylate cyclase, increasing intracellular cAMP, which promotes insertion of aquaporin‑2 water channels into the apical membrane, thereby enhancing water reabsorption. In endothelial cells, V2‑receptor activation triggers release of stored factor VIII and von Willebrand factor, augmenting haemostatic activity.

Side Effects

Desmopressin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Hyponatremia: mild reduction in serum sodium.
  • Headache: transient cranial discomfort.
  • Nausea: occasional gastrointestinal upset.
  • Facial flushing: brief reddening of the skin.

Serious or Rare Side Effects

  • Severe hyponatremia: can cause confusion, seizures, or coma.
  • Water intoxication: excessive fluid retention leading to edema.
  • Allergic reaction: rash, itching, or swelling.

Precautions & Warnings

When prescribing desmopressin, clinicians should observe several precautionary measures to minimize risk.

  • Assess renal function: evaluate kidney performance before initiating therapy.
  • Monitor serum sodium: check electrolytes regularly, especially in patients at risk of hyponatremia.
  • Limit fluid intake: advise patients to restrict excessive water consumption while on treatment.
  • Use with caution in elderly: older adults have higher susceptibility to water retention and electrolyte imbalance.
  • Avoid concomitant hyponatremia‑inducing drugs: review medication list for diuretics or SSRIs.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Desmopressin can interact with several medicines that affect water balance or its antidiuretic effect.

Major Interactions (Avoid)

  • Concomitant use with carbamazepine: may reduce desmopressin efficacy.
  • Co‑administration with thiazide diuretics: increases risk of hyponatremia.
  • Combination with selective serotonin reuptake inhibitors (SSRIs): potentiates hyponatremia.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may enhance antidiuretic effect, requiring sodium monitoring.
  • Anticonvulsants such as phenobarbital: may lower plasma levels of desmopressin.

Frequently Asked Questions

Nocutil Melt contains desmopressin and is prescribed for central diabetes insipidus, nocturnal enuresis, and to reduce bleeding in patients with hemophilia A or von Willebrand disease. It works by increasing water reabsorption and enhancing clotting factor release.

Desmopressin acts as a synthetic analogue of vasopressin. It selectively stimulates V2 receptors in the kidney, raising cAMP levels and promoting insertion of aquaporin‑2 channels, which increase water reabsorption. In endothelial cells it triggers release of factor VIII and von Willebrand factor, supporting haemostasis.

The appropriate dose of Nocutil Melt is determined by the prescribing clinician based on the individual’s condition, age, renal function and response to therapy. Dosage instructions are provided on the prescription label and should not be altered without medical guidance.

Safety data for desmopressin in pregnancy and lactation are limited. The product’s pregnancy category is unknown, and it should only be used if the potential benefit justifies any possible risk to the fetus or infant. Consultation with a healthcare professional is essential.

To request Nocutil Melt, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Desmopressin is a selective V2‑receptor agonist, offering a longer duration of action and a lower risk of vasoconstriction compared with older agents like vasopressin. Its sublingual melt formulation provides rapid absorption and convenient dosing, making it a preferred option for many patients.

Nocutil Melt should be stored at ambient temperature, below 25 °C. Keep the melt in its original packaging, protect it from moisture, and avoid exposure to direct sunlight or excessive heat to maintain product stability.

The melt is placed under the tongue and allowed to dissolve completely without chewing or swallowing water first. This sublingual route enables rapid absorption into the bloodstream, providing the intended therapeutic effect.

The most serious risks include severe hyponatremia, which can lead to confusion, seizures or coma, and water intoxication resulting in significant fluid overload. Prompt monitoring of serum sodium and fluid balance is essential to mitigate these hazards.

Patients with uncontrolled hyponatremia, severe renal impairment, or known hypersensitivity to desmopressin should avoid Nocutil Melt. Additionally, individuals taking medications that markedly increase the risk of hyponatremia should be evaluated carefully before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.